Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Organon & Co’s current trading price is -59.44% away from its 52-week high, while its distance from the 52-week low is 16.98%. The stock’s price range during this period has varied between $8.01 and $23.10. The company, active in the Healthcare sector, saw a trading volume of around 3.53 million for the day, considerably lower average daily volume of 4.37 million observed over the last three months.
Organon & Co (OGN) currently has a stock price of $9.37. The stock saw a sharp increase in the last trading session, hitting a high of $18.0 after opening at $9.37. The lowest recorded price for the day was $9.0 before it closed at $9.26.
Organon & Co’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $23.10 on 08/26/24, and the lowest price during the same period was recorded at $8.01 on 05/14/25.
How Financial Performance Impacts Market Capitalization
Organon & Co (OGN) has experienced a quarterly rise of 6.96% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.44B and boasts a workforce of 10000 employees.
Decoding Analysts’ Ratings for Organon & Co
As of right now, 0 analyst is rating Organon & Co as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts are recommending to HOLD this stock, 2 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.15, with a change in price of -5.19. Similarly, Organon & Co recorded 5,174,589 in trading volume during the last 100 days, posting a change of -35.65%.
How OGN’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for OGN stands at 12.14. Similarly, the long-term debt-to-equity ratio is also 11.98.
OGN Stock Stochastic Average
As of today, the raw stochastic average of Organon & Co over the past 50 days is 49.65%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 50.84%. Additionally, the Stochastic %K and %D values for the company were 47.63% and 49.08%, respectively, over the past 20 days.
OGN Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -53.96%.However, over the last six months, we can see a stronger performance of -38.72%. Over the last 30 days, the price of OGN has leaped by -4.58%. And in the last five days, it has surged by 0.11%.
